KOALA CAR-T trial doses first myeloma patient - SelectScience news
First patient dosed in the KOALA trial of a novel KMA-targeting CAR T-cell therapy for multiple myeloma. Read expert insights on SelectScience.
selectscience.net
First patient dosed in the KOALA trial of a novel KMA-targeting CAR T-cell therapy for multiple myeloma. Read expert insights on SelectScience.
Discover how age-related oligodendrocyte dysfunction may damage myelin and drive cognitive decline. Read expert insights on SelectScience.
Discover how Holyoke Medical Center boosts clinical chemistry QC with analyzer-ready controls, peer data, and Six Sigma. Read expert insights onโฆ
Experts from Xbrane Biopharma discuss the biosimilar development process and how bioassays are the driving force behind reduced cost and accelerโฆ
Gain insights on topics from metabolomics to high-resolution genome libraries, CRISPR innovations advancing translational research, and more
Scientific, technological and communications excellence has been celebrated at the Virtual Cancer and Immunology Research Summit, with Logos Bioโฆ
In this Q&A from our popular webinar, learn about an analytical procedure implemented by the pharmaceutical industry and how it can benefit yourโฆ